Prescription Drug & Vaccine Developers

Own companies whose core business is discovering and commercializing prescription medicines and vaccines, with demand tied to patient treatment rather than infrastructure spending. With tonight's headlines concentrated on AI infrastructure, this basket offers a distinct source of business exposure. Established treatment franchises provide commercial breadth, while clinical development and patent expirations remain important risks. Launch basket (equal weight): ABBV, AMGN, LLY, MRK, MRNA, GILD, VRTX Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.